The Colorado Symphony is taking advantage of the recent legalization of marijuana in that state.
According to The Denver Post, the organization has “announced a series of performances sponsored by the cannabis industry. The concerts, organized by pro-pot promoter Edible Events, will start May 23 with three bring-your-own marijuana events at the Space Gallery in Denver’s Santa Fe arts district and culminate with a large, outdoor performance at Red Rocks Amphitheater on Sept. 13. The events are being billed as fundraisers for the CSO, which will curate a themed program of classical music for each show.”
The orchestra’s website indicates that the program is being called “Classically Cannabis: The High Note Series.”
While I love the idea and think it makes a tremendous amount of sense, I’d encourage the orchestra’s artistic director, Andrew Litton, and his colleagues, not to overthink the programming.
Later this year, the Colorado Symphony is scheduled to perform works by contemporary American composers John Adams and Cindy McTee alongside iconic pieces of repertoire by the likes of Gustav Mahler, including his Symphony No. 1 and Blumine, a piece of incidental music that Mahler included in his first symphony and then edited out.
My point here is that the Colorado Symphony’s “Classically Cannabis: The High Note Series” certainly has the potential to score (if you’ll pardon the pun) some new audience members. And I certainly hope that it’s a success — and that the orchestra introduces itself authentically to those new audience members.
I for one would love to get into the mood and hear the orchestra play Adams’ Short Ride in a Fast Machine, Rachmaninoff Piano Concerto No. 3, Mahler’s Blumine, and Mahler Symphony No. 1 — all of which it’s already scheduled to perform this season. If not in person, I’ll be there in spirit. I’m already applauding the Colorado Symphony’s innovative thinking.
— David Brensilver